Rheumatoid arthritis patients can be reasonably used tofacitibe for treatment, but the specific treatment program needs to be formulated by professional physicians according to the patient’s condition.
Tofacitib is a kind of immune function regulation drugs, the drug through the inhibition of tyrosine protein kinase affects the cellular immune function and cell hematopoietic process, and then play the role of immunomodulation or immunosuppression, can be used alone or with methotrexate and other non-biological anti-rheumatic drugs used in the treatment of moderate and severe active rheumatoid arthritis.
Tofacitib adverse drug reactions include inflammatory infections, gastrointestinal perforation, malignant tumors and abnormal laboratory tests. Allergic to the drug is contraindicated, pregnant and lactating women use the drug there is a drug risk, in addition, female patients should be contraceptive and family planning when using this product. Pay attention to the prevention and control of infections during the use of the drug, regular monitoring of liver and kidney function.
Tofacitib should be used strictly under the guidance of a physician, it is recommended that patients with rheumatoid arthritis who need to take Tofacitib go to the rheumatology and immunology department of a regular hospital for a detailed consultation, to avoid taking the drug on their own.